THC Biomed Intl (THCBF) Stock Price, News & Analysis

Company Overview

THC Biomed International Inc. is a life sciences company focused on the research, development and commercialization of cannabis-derived pharmaceuticals, nutraceuticals and health and wellness products. Leveraging proprietary extraction and purification technologies, the company produces a broad spectrum of cannabinoid isolates, full-spectrum extracts, oils, tinctures, edibles and topicals. Its product pipeline includes formulations designed to address pain management, sleep disorders, anxiety and other unmet medical needs, as well as consumer-oriented wellness offerings.

Founded in British Columbia, THC Biomed has established cultivation and production facilities in Canada, backed by Good Manufacturing Practices (GMP) certification. The company has also entered into strategic partnerships and licensing agreements to expand its reach into Europe, Latin America and select Asian markets. Through alliances with academic institutions and contract research organizations, THC Biomed conducts preclinical and clinical studies aimed at validating the safety, efficacy and consistency of its cannabinoid-based therapies.

THC Biomed’s leadership team brings together expertise in pharmacology, natural product chemistry and regulatory affairs. The executive suite is headed by a Chief Executive Officer with over two decades of experience in pharmaceutical development, supported by a research and development director who has led multiple drug discovery programs. The board of directors includes industry veterans in biotech financing, international distribution and health policy.

Committed to innovation and compliance, THC Biomed maintains a pipeline of novel cannabinoid formulations designed for specialty and mainstream channels. By integrating state-of-the-art extraction methods with rigorous quality control, the company aims to deliver consistent, scientifically backed products. Its strategic vision encompasses both prescription-grade therapeutics and accessible wellness solutions, positioning THC Biomed International at the forefront of the global cannabinoid market.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 7,900 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

THCBF Stock Analysis - Frequently Asked Questions

How do I buy shares of THC Biomed Intl?

Shares of THCBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:THCBF
• CIK: N/A
• Web: thcbiomed.com
• Phone: (844) 842-6337
• Fax: N/A
• Employees: 35
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A